Pharma BD Deal Intelligence
Schering AG / Collateral Therapeutics Inc.
2002 · Acquisition/Merger · $140M · Complete
Announcement Sentiment
67
Positive
Announced 2002. $140M stock-for-stock. Schering already held 12% stake. Cardiovascular gene therapy. FTC early termination granted. Tier 2 (FTC) + Tier 6 verified.
Key facts
- Announced Mar 20, 2002
- Closed Jul 02, 2002
- Deal value $140M
- Deal type Acquisition/Merger
See the full interactive analysis, sources & comparables →
← Browse all deals ·
How we score deals